Home
About
Profile
Milestone
Honor
Culture
Responsibility
Products
Prevention and treatment of heart failure
Cardiogenic stroke
Valvular disease
Intervention consumables
Clinical trial
Technology platform
R&d results
Intellectual property
Industry-university-research cooperation
News
Company dynamics
Industry information
Application case
HR
Talent concept
Talent recruitment
Contact
Contact Information
Online message
2025-08-15
World's First TAVR vs. SAVR Trial for Intermediate-to-High Risk Aortic Regurgitation Nears Completion!
2025-05-08
Charting the Grand Blueprint · Pioneering the Future | Warm Congratulations on the Grand Opening of Vickor QiYuan (Wuxi) Medical Technology Co., Ltd.!
2024-12-21
Vickor Medical: Series C Funding Successfully Closed, Fueling a New Chapter with Hundreds of Millions in Capital!
2024-10-15
Featured Case | Successful PFO Closure Facilitated by the Astross Delivery System in Complex Anatomy
2024-08-03
Featured Case | Successful Closure of PFO with Multifenestrated ASD and ASA Using D-shufo®'s Innovative Asymmetric Disc Design
2024-01-10
Vickor Medical Science and Technology Association was established
Wuhan Vickor Medical Technology Co., Ltd. (hereinafter referred to as "Vickor Medical ") Science and Technology Association establishment conference was held successfully!
2023-12-29
Vickor Medical "Arkcess® Left Ventricular Wire" approved NMPA registration Certificate!
The "Left ventricular guide wire" independently developed by Vickor Medical has obtained the registration certificate of the National Medical Products Administration (NMPA) (Registration Certificate number: National Instrument Registration Permit 20233032030).
©2023 Wuhan Vickor Medical Technology Co., Ltd.
This site already supports IPV6 access | SEO | Business License
您可以查看其他栏目或返回 首页
You can view other columns or return Home
